MaxCyte (MXCT) Competitors GBX 2.28 +0.03 (+1.33%) As of 07/10/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock MXCT vs. MAST, ADV, ABM, RGP, LEAF, NEO, TCY, ACM, PRG, and AMFWShould you be buying MaxCyte stock or one of its competitors? The main competitors of MaxCyte include MAST Energy Developments (MAST), Advance Energy (ADV), African Battery Metals (ABM), Ross Group (RGP), Leaf Clean Energy (LEAF), Neo Energy Metals (NEO), 1619348 (TCY.L) (TCY), 435793 (ACM.L) (ACM), 49379 (PRG.L) (PRG), and AMFW.L (AMFW). These companies are all part of the "business services" industry. MaxCyte vs. Its Competitors MAST Energy Developments Advance Energy African Battery Metals Ross Group Leaf Clean Energy Neo Energy Metals 1619348 (TCY.L) 435793 (ACM.L) 49379 (PRG.L) AMFW.L MAST Energy Developments (LON:MAST) and MaxCyte (LON:MXCT) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations. Which has more volatility and risk, MAST or MXCT? MAST Energy Developments has a beta of -0.58, indicating that its share price is 158% less volatile than the S&P 500. Comparatively, MaxCyte has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Does the media prefer MAST or MXCT? In the previous week, MAST Energy Developments had 1 more articles in the media than MaxCyte. MarketBeat recorded 1 mentions for MAST Energy Developments and 0 mentions for MaxCyte. MAST Energy Developments' average media sentiment score of 1.32 beat MaxCyte's score of 0.00 indicating that MAST Energy Developments is being referred to more favorably in the media. Company Overall Sentiment MAST Energy Developments Positive MaxCyte Neutral Do institutionals and insiders believe in MAST or MXCT? 0.2% of MAST Energy Developments shares are held by institutional investors. Comparatively, 70.5% of MaxCyte shares are held by institutional investors. 27.7% of MAST Energy Developments shares are held by insiders. Comparatively, 1.5% of MaxCyte shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is MAST or MXCT more profitable? MAST Energy Developments has a net margin of 0.00% compared to MaxCyte's net margin of -78.37%. MaxCyte's return on equity of -16.01% beat MAST Energy Developments' return on equity.Company Net Margins Return on Equity Return on Assets MAST Energy DevelopmentsN/A -695.03% -14.56% MaxCyte -78.37%-16.01%-11.07% Which has stronger earnings & valuation, MAST or MXCT? MAST Energy Developments has higher earnings, but lower revenue than MaxCyte. MAST Energy Developments is trading at a lower price-to-earnings ratio than MaxCyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMAST Energy Developments£1.04M6.48-£3.26M-£0.01-158.00MaxCyte£57.52M0.05-£45.08M-£27.29-0.08 SummaryMAST Energy Developments beats MaxCyte on 7 of the 13 factors compared between the two stocks. Get MaxCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MXCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MXCT vs. The Competition Export to ExcelMetricMaxCyteMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£3.01M£3.41B£5.60B£3.00BDividend YieldN/A2.44%5.24%5.02%P/E Ratio-0.0874.3527.96150.83Price / Sales0.05102.97430.57314,599.97Price / Cash1.9715.9937.4627.97Price / Book0.013.848.044.59Net Income-£45.08M£132.05M£3.18B£5.90B7 Day Performance2.01%1.83%3.63%11.51%1 Month Performance-98.62%8.66%4.04%7.92%1 Year Performance-99.34%9.97%29.56%32.05% MaxCyte Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MXCTMaxCyteN/AGBX 2.28+1.3%N/A-99.4%£3.01M£57.52M-0.0880High Trading VolumeMASTMAST Energy DevelopmentsN/AGBX 1.26+0.6%N/A+1,061.8%£5.36M£1.04M-125.7029,900News CoverageADVAdvance EnergyN/AN/AN/AN/A£2.67M£16K-0.2975,000Gap UpHigh Trading VolumeABMAfrican Battery MetalsN/AN/AN/AN/A£2.00MN/A-0.12127,000Gap DownRGPRoss GroupN/AN/AN/AN/A£1.63M£43K-90.004,260Gap DownLEAFLeaf Clean EnergyN/AN/AN/AN/A£458K-£2M2.80346Positive NewsGap DownHigh Trading VolumeNEONeo Energy MetalsN/AGBX 0.01flatN/AN/A£102KN/A-0.022,100TCY1619348 (TCY.L)N/AN/AN/AN/A£0.00N/A0.004,800ACM435793 (ACM.L)N/AN/AN/AN/A£0.00N/A0.0050,000PRG49379 (PRG.L)N/AN/AN/AN/A£0.00N/A0.001,690High Trading VolumeAMFWAMFW.LN/AN/AN/AN/A£0.00N/A0.0034,013 Related Companies and Tools Related Companies MAST Energy Developments Competitors Advance Energy Competitors African Battery Metals Competitors Ross Group Competitors Leaf Clean Energy Competitors Neo Energy Metals Competitors 1619348 (TCY.L) Competitors 435793 (ACM.L) Competitors 49379 (PRG.L) Competitors AMFW.L Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MXCT) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
